ACORN BIOVENTURES, L.P. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:44 pm Purchase |
2022-06-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ACORN BIOVENTURES, L.P. | 17,755,869 9.990% |
17,755,869 (New Position) |
Filing |